Clinical Trials Logo

Clinical Trial Summary

Central retinal artery occlusions (CRAO) are the equivalent of an ischemic stroke (IS) at the retinal level. They share the same risk factors and common pathology. Their incidence is lower (8.5 / 100,000) and the functional prognosis is unfavorable in 80% of cases with visual acuity (VA) <1/10. The diagnosis of an CRAO is clinically based on the sudden occurrence of a decrease in deep visual acuity with fundamentally signs of reactive ischemia. There is no data on early retinal arterial recanalization after CRAO, nor on the relationship between early recanalization (spontaneous or post-thrombolysis) and visual prognosis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03049514
Study type Observational
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact
Status Completed
Phase
Start date December 23, 2016
Completion date April 2, 2022

See also
  Status Clinical Trial Phase
Completed NCT02390245 - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study N/A
Recruiting NCT04526951 - TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) Phase 3
Recruiting NCT04965038 - Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion Phase 3
Recruiting NCT01348633 - Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye N/A
Completed NCT03197194 - A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion Phase 3
Recruiting NCT05562284 - Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion N/A
Completed NCT05739487 - Changes of Visual Field Defects After IAT for CRAO
Terminated NCT00802698 - The Effect of Transcorneal Stimulation in Cases of Central Retinal Artery Occlusion Using a New Waveform N/A
Recruiting NCT06178055 - A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arthritic Central Retinal Artery Occlusion (CRAO) Phase 2